A Phase II Trial of Individualized Stereotactic Ablative Radiotherapy for Lung Tumors (iSABR)

被引:0
作者
Gensheimer, M. F. [1 ]
Gee, H. E. [2 ,3 ]
Von Eyben, R. [4 ]
Shirato, H. [5 ]
Taguchi, H. [5 ]
Wong, S. [4 ]
Brown, E. [4 ]
Nguyen, N. [4 ]
Liang, R. [4 ]
Maxim, P. G. [6 ]
Wakelee, H. A. [7 ]
Neal, J. W. [7 ]
Das, M. [7 ]
Loo, B. W., Jr. [4 ]
Diehn, M. [4 ]
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, Palo Alto, CA 94304 USA
[2] Sydney West Radiat Oncol Network, Sydney, NSW, Australia
[3] Univ Sydney, Sydney, NSW, Australia
[4] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA
[5] Hokkaido Univ, Fac Med, Dept Radiat Med, Sapporo, Hokkaido, Japan
[6] Indiana Univ Sch Med, Dept Radiat Oncol, Indianapolis, IN 46202 USA
[7] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
174
引用
收藏
页码:S89 / S90
页数:2
相关论文
empty
未找到相关数据